Xiaolong Chen

Professor Chen and his team have decades of experience working with Validamycin. Their research originally spanned its initial discovery, development and production as an agricultural antibiotic, and is now focussed on exploring its recent adaptation to a pharmaceutical lead with a multitude of potential applications. The group have published numerous papers on their work, including an important review on the preparation of Validamycin derivative Valienamine in 2003, followed by another key...See more

Professor Chen and his team have decades of experience working with Validamycin. Their research originally spanned its initial discovery, development and production as an agricultural antibiotic, and is now focussed on exploring its recent adaptation to a pharmaceutical lead with a multitude of potential applications. The group have published numerous papers on their work, including an important review on the preparation of Validamycin derivative Valienamine in 2003, followed by another key review on the preparation of Voglibose in 2006. In addition, they hold a number of patents relating to the degradation of Validamycin to produce Valienamine. See less